Tripep Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Tripep General Information

Description

Provider of biotechnology research services. The company's biotechnology research services focuses on the development and commercialization of candidate drugs based on patented technologies which includes development of a potential HIV-inhibiting drug, preclinical research focusing on the development of therapeutic and prophylactic vaccines against HIV and Hepatitis C and RAS technology platform.

Contact Information

Website
www.tripep.se
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Hälsovägen 7
  • 141 57 Huddinge
  • Sweden
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Din Bostad Sverige
Vertical(s)
Life Sciences
Corporate Office
  • Hälsovägen 7
  • 141 57 Huddinge
  • Sweden

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tripep Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 25-Aug-2006 Completed Generating Revenue
3. PIPE 10-Nov-2003 Completed Generating Revenue
2. IPO 01-Jan-2000 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Tripep’s complete valuation and funding history, request access »

Tripep Patents

  • 166

    Total Documents Applications and Grants

  • Total Patents Families

  • 50

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Tripep Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140121587-A1 Injection needle and device Active 15-Jun-2011
US-9457183-B2 Injection needle and device Inactive 15-Jun-2011
US-20140286985-A1 Simple vaccines from dna launched suicidal flaviviruses Inactive 11-May-2010
US-20130012865-A1 Codon-optimzed hepatitis b virus core antigen (hbcag) Inactive 16-Dec-2009
US-20130011375-A1 T cell receptors specific for immunodominant ctl epitopes of hcv Active 24-Nov-2009 C07K14/7051
To view Tripep’s complete patent history, request access »

Tripep Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
HealthCap Venture Capital Minority
Angel (individual) Minority
To view Tripep’s complete investors history, request access »

Ready to get started?

Request a free trial

Tripep FAQs

  • When was Tripep founded?

    Tripep was founded in 1997.

  • Where is Tripep headquartered?

    Tripep is headquartered in Huddinge, Sweden.

  • What industry is Tripep in?

    Tripep’s primary industry is Biotechnology.

  • Is Tripep a private or public company?

    Tripep is a Private company.

  • What is Tripep’s current revenue?

    The current revenue for Tripep is .

  • Who are Tripep’s investors?

    HealthCap and have invested in Tripep.

  • When was Tripep acquired?

    Tripep was acquired on 25-Aug-2006.

  • Who acquired Tripep?

    Tripep was acquired by Din Bostad Sverige.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »